| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2003PNAS..10012367P |
| P356 | DOI | 10.1073/PNAS.2032886100 |
| P8608 | Fatcat ID | release_bpkpo65rd5d47lobojszqzxlxu |
| P953 | full work available at URL | https://europepmc.org/articles/pmc218764?pdf=render |
| https://europepmc.org/articles/PMC218764 | ||
| https://europepmc.org/articles/PMC218764?pdf=render | ||
| https://doi.org/10.1073/pnas.2032886100 | ||
| https://pnas.org/doi/pdf/10.1073/pnas.2032886100 | ||
| P932 | PMC publication ID | 218764 |
| P698 | PubMed publication ID | 14519852 |
| P5875 | ResearchGate publication ID | 9071325 |
| P2093 | author name string | Ming Bao | |
| Ming He | |||
| Patrick Andre | |||
| David R. Phillips | |||
| Jeanne Manganello | |||
| K. S Srinivasa Prasad | |||
| P2860 | cites work | Identification of the platelet ADP receptor targeted by antithrombotic drugs | Q24290845 |
| CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells | Q24310570 | ||
| Reduction of atherosclerosis in mice by inhibition of CD40 signalling | Q24316540 | ||
| Interactions between Eph kinases and ephrins provide a mechanism to support platelet aggregation once cell-to-cell contact has occurred | Q24534800 | ||
| 2 A crystal structure of an extracellular fragment of human CD40 ligand | Q27732546 | ||
| Signaling through platelet integrin alpha IIb beta 3: inside-out, outside-in, and sideways | Q28140857 | ||
| Molecular and biological characterization of a murine ligand for CD40 | Q28186605 | ||
| Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation | Q28188284 | ||
| Inhibitory effects of glycoprotein IIb/IIIa antagonists and aspirin on the release of soluble CD40 ligand during platelet stimulation | Q28195169 | ||
| Platelets adhere to and translocate on von Willebrand factor presented by endothelium in stimulated veins | Q28507544 | ||
| Outside-in integrin signal transduction. Alpha IIb beta 3-(GP IIb IIIa) tyrosine phosphorylation induced by platelet aggregation | Q28609213 | ||
| A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee | Q29620666 | ||
| Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. | Q30310323 | ||
| Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis. | Q31929744 | ||
| Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets. | Q33183129 | ||
| Role of CD40-CVD40L in mouse severe malaria | Q33338408 | ||
| Thrombocytopenia in an animal model of malaria is associated with an increased caspase-mediated death of thrombocytes | Q33341223 | ||
| Cardiopulmonary bypass induces release of soluble CD40 ligand | Q33342885 | ||
| Platelet integrin GPIIb/IIIa: structure-function correlations. An update and lessons from other integrins | Q33746192 | ||
| Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice | Q33903557 | ||
| Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery | Q34531963 | ||
| Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype | Q35161070 | ||
| Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis | Q36028683 | ||
| Adhesion of platelets to surface-bound fibrinogen under flow | Q39433369 | ||
| CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. | Q40658295 | ||
| Soluble CD40L and cardiovascular risk in women | Q40677583 | ||
| Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III. | Q40918338 | ||
| Human native soluble CD40L is a biologically active trimer, processed inside microsomes | Q41216181 | ||
| Integrin cytoplasmic tyrosine motif is required for outside-in alphaIIbbeta3 signalling and platelet function | Q41700251 | ||
| Identification of shc as the primary protein binding to the tyrosine-phosphorylated beta 3 subunit of alpha IIbbeta 3 during outside-in integrin platelet signaling | Q41758432 | ||
| Proceedings of the Society for Experimental Biology and Medicine | Q45038026 | ||
| Cloning of TRAP, a ligand for CD40 on human T cells | Q48147375 | ||
| The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. | Q52962713 | ||
| A flow cytometric assay using mepacrine for study of uptake and release of platelet dense granule contents | Q56502430 | ||
| CD40L stabilizes arterial thrombi by a β3 integrin–dependent mechanism | Q63354517 | ||
| Does the conformation of adsorbed fibrinogen dictate platelet interactions with artificial surfaces? | Q69565210 | ||
| Amyloid beta-protein precursor-rich platelet microparticles in thrombotic disease | Q71677831 | ||
| Localization of a site interacting with human platelet receptor on carboxy-terminal segment of human fibrinogen γ chain | Q72956213 | ||
| CD40L activation in circulating platelets in patients with acute coronary syndrome | Q73368214 | ||
| Tyrosine phosphorylation of the beta3 cytoplasmic domain mediates integrin-cytoskeletal interactions | Q74567473 | ||
| Genetic and pharmacological analyses of Syk function in alphaIIbbeta3 signaling in platelets | Q77293881 | ||
| Incorporation of an isoleucine zipper motif enhances the biological activity of soluble CD40L (CD154) | Q77732931 | ||
| Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes | Q78108701 | ||
| P433 | issue | 21 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | phosphorylation | Q242736 |
| P304 | page(s) | 12367-12371 | |
| P577 | publication date | 2003-09-30 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Soluble CD40 ligand induces beta3 integrin tyrosine phosphorylation and triggers platelet activation by outside-in signaling | |
| Soluble CD40 ligand induces β 3 integrin tyrosine phosphorylation and triggers platelet activation by outside-in signaling | |||
| P478 | volume | 100 |
| Q36661866 | A Novel Pentapeptide Targeting Integrin β3-Subunit Inhibits Platelet Aggregation and Its Application in Rat for Thrombosis Prevention |
| Q34514603 | A soluble LAG-3 protein as an immunopotentiator for therapeutic vaccines: Preclinical evaluation of IMP321. |
| Q34002877 | Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells |
| Q58481433 | Antiplatelet drugs |
| Q35813773 | Association between Serum Soluble CD154 Levels and Mortality in Patients with Malignant Middle Cerebral Artery Infarction. |
| Q35559467 | Association between serum soluble CD40 ligand levels and mortality in patients with severe sepsis. |
| Q91644478 | Bacteriophage and the Innate Immune System: Access and Signaling |
| Q37479464 | Beta integrin tyrosine phosphorylation is a conserved mechanism for regulating talin-induced integrin activation |
| Q52666720 | Blocking α5β1 Integrin Attenuates sCD40L-Mediated Platelet Activation. |
| Q21285053 | CD154: an immunoinflammatory mediator in systemic lupus erythematosus and rheumatoid arthritis |
| Q38083874 | CD154: the atherosclerotic risk factor in rheumatoid arthritis? |
| Q40191634 | CD40 ligand binds to alpha5beta1 integrin and triggers cell signaling |
| Q37017170 | CD40/CD40L system and vascular disease. |
| Q90669240 | CD40L Priming of Platelets via NF-κB Activation is CD40- and TAK1-Dependent |
| Q33814059 | CD40L and Its Receptors in Atherothrombosis-An Update |
| Q41983901 | Cadherin 6 has a functional role in platelet aggregation and thrombus formation |
| Q41824131 | Characterization of ASKP1240, a fully human antibody targeting human CD40 with potent immunosuppressive effects |
| Q49036941 | Chronic hyper-reactivity of platelets resulting in enhanced monocyte recruitment in patients after ischaemic stroke. |
| Q50614844 | Comparative Evaluation of αCD40 (2C10R4) and αCD154 (5C8H1 and IDEC-131) in a Nonhuman Primate Cardiac Allotransplant Model. |
| Q35525691 | Critical role for Syk in responses to vascular injury |
| Q27666816 | Crystallographic and Mutational Analysis of the CD40-CD154 Complex and Its Implications for Receptor Activation |
| Q52345148 | Cytokine Responses in Severe Traumatic Brain Injury: Where There Is Smoke, Is There Fire? |
| Q33400949 | Decreased plasma cytokines are associated with low platelet counts in aplastic anemia and immune thrombocytopenic purpura |
| Q39818970 | Deficiencies in the CD40 and CD154 receptor-ligand system reduce experimental lung metastasis. |
| Q24293698 | Evidence for a role of ADAM17 (TACE) in the regulation of platelet glycoprotein V |
| Q45237822 | GPIIb-IIIa antagonists reduce thromboinflammatory processes in patients with acute coronary syndromes undergoing percutaneous coronary intervention |
| Q50722340 | Generation of mice with conditional ablation of the Cd40lg gene: new insights on the role of CD40L. |
| Q92819374 | High Serum sCD40L Levels During the First Week of Malignant Middle Cerebral Artery Infarction and Mortality |
| Q42880920 | Human platelets express and are activated by galectin-8. |
| Q21245663 | IMP321 (sLAG-3), an immunopotentiator for T cell responses against a HBsAg antigen in healthy adults: a single blind randomised controlled phase I study |
| Q36223037 | Inflammation and circulating endothelial progenitor cells in patients with coronary artery disease and residual platelet reactivity |
| Q36228035 | Integrin signaling is critical for pathological angiogenesis |
| Q38939816 | Interaction of CD154 with different receptors and its role in bidirectional signals. |
| Q37196287 | Microfluidic devices for studies of shear-dependent platelet adhesion |
| Q34630514 | Microvascular thrombosis and CD40/CD40L signaling |
| Q34422566 | Multifunctional CD40L: pro- and anti-neoplastic activity |
| Q26768672 | New Prognostic Biomarkers in Patients With Traumatic Brain Injury |
| Q43182095 | New frontiers for platelet CD154. |
| Q57482211 | New prognostic biomarkers of mortality in patients undergoing liver transplantation for hepatocellular carcinoma |
| Q42958884 | New steroidal glycosides isolated as CDL inhibitors of activated platelets. |
| Q92706741 | Nonsurviving Patients with Severe Traumatic Brain Injury Have Maintained High Serum sCD40L Levels |
| Q51418884 | Organ-on-Chip Recapitulates Thrombosis Induced by an anti-CD154 Monoclonal Antibody: Translational Potential of Advanced Microengineered Systems. |
| Q34490668 | Ovariectomy disregulates osteoblast and osteoclast formation through the T-cell receptor CD40 ligand |
| Q37215124 | Ovariectomy expands murine short-term hemopoietic stem cell function through T cell expressed CD40L and Wnt10B. |
| Q35838444 | P-selectin in haemostasis |
| Q51806105 | Pathological shear stress directly regulates platelet alphaIIbbeta3 signaling. |
| Q51173170 | Plasma kallikrein enhances platelet aggregation response by subthreshold doses of ADP. |
| Q47645034 | Platelet CD40 Mediates Leukocyte Recruitment and Neointima Formation after Arterial Denudation Injury in Atherosclerosis-Prone Mice |
| Q37809369 | Platelet CD40L at the interface of adaptive immunity |
| Q89169483 | Platelet Signaling and Disease: Targeted Therapy for Thrombosis and Other Related Diseases |
| Q33896059 | Platelet activity and cardiovascular risk in apparently healthy individuals: a review of the data |
| Q33371797 | Platelet and soluble CD40L in meningococcal sepsis. |
| Q28236789 | Platelet integrin alpha(IIb)beta(3): activation mechanisms |
| Q37807924 | Platelet receptor signaling in thrombus formation |
| Q34708937 | Platelet transfusions: impact on hemostasis, thrombosis, inflammation and clinical outcomes |
| Q91962280 | Platelets Are Critical Key Players in Sepsis |
| Q38017397 | Platelets and cytokines: How and why? |
| Q37657202 | Platelets and innate immunity |
| Q36230859 | Platelets in atherothrombosis: lessons from mouse models |
| Q28221912 | Release of biologically active CD154 during collection and storage of platelet concentrates prepared for transfusion |
| Q28584706 | Role of Gas6 receptors in platelet signaling during thrombus stabilization and implications for antithrombotic therapy |
| Q28069254 | Role of Platelet-Derived Microvesicles As Crosstalk Mediators in Atherothrombosis and Future Pharmacology Targets: A Link between Inflammation, Atherosclerosis, and Thrombosis |
| Q24310575 | Role of the growth arrest-specific gene 6 (gas6) product in thrombus stabilization |
| Q51758607 | Roles of Mac-1 and glycoprotein IIb/IIIa integrins in leukocyte-platelet aggregate formation: stabilization by Mac-1 and inhibition by GpIIb/IIIa blockers. |
| Q41702340 | Serum soluble CD40 ligand levels after acute intracerebral hemorrhage |
| Q34548104 | Signaling protein SWAP-70 is required for efficient B cell homing to lymphoid organs |
| Q46845923 | Soluble CD40L, platelet surface CD40L and total platelet CD40L in congestive heart failure: relationship to platelet volume, mass and granularity |
| Q42557418 | Statin islands and PPAR ligands in platelets |
| Q35224501 | T cell-expressed CD40L potentiates the bone anabolic activity of intermittent PTH treatment |
| Q36717261 | T cells, osteoblasts, and osteocytes: interacting lineages key for the bone anabolic and catabolic activities of parathyroid hormone |
| Q33787816 | Tenectin is a novel alphaPS2betaPS integrin ligand required for wing morphogenesis and male genital looping in Drosophila |
| Q90723624 | The CD40-CD40L Dyad as Immunotherapeutic Target in Cardiovascular Disease |
| Q37829738 | The CD40-CD40L system in cardiovascular disease. |
| Q36070900 | The Interaction of CD154 with the α5β1 Integrin Inhibits Fas-Induced T Cell Death |
| Q36445381 | The PPAR-Platelet Connection: Modulators of Inflammation and Potential Cardiovascular Effects |
| Q33937074 | The platelet as an immune cell-CD40 ligand and transfusion immunomodulation |
| Q87841178 | The search for new antithrombotic mechanisms and therapies that may spare hemostasis |
| Q26863134 | The signaling role of CD40 ligand in platelet biology and in platelet component transfusion |
| Q33412254 | Therapeutic drug-induced platelet apoptosis: an overlooked issue in pharmacotoxicology |
| Q38725992 | Transfusion-related acute lung injury: transfusion, platelets and biological response modifiers |
Search more.